- Home
- JMM vs SRTS Comparison
JMM vs SRTS Comparison
Compare JMM & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JMM | SRTS |
|---|---|---|
| Founded | 1988 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.8M | 65.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | JMM | SRTS |
|---|---|---|
| Price | $5.87 | $3.97 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 5.4K | ★ 28.6K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 5.44% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.70 | $3.03 |
| 52 Week High | $6.52 | $5.92 |
Technical Indicators
Market Signals| Indicator | JMM | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 45.07 |
| Support Level | $5.73 | $3.66 |
| Resistance Level | $5.94 | $4.60 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 23.53 | 28.00 |
Price Performance
Historical ComparisonAbout JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.